Forensic Analysis · Healthcare / Pharmaceuticals / Biotech
Merck & Co., Inc. (MRK)
A forensic read on Merck & Co., Inc. built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.
A · High-quality compounder
Forensic grade
75
Rating (0–100)
32.4
P / E
$284.4B
Market cap
2.95%
Dividend yield
The full forensic report — free
🔒Every red flag on MRK, detailed and traced to the filing
🔒Altman Z distress & Beneish M earnings-quality screens
🔒Calibrated 12-month price forecast + reverse-DCF
🔒Earnings-quality & capital-allocation forensics
No credit card · informational only, not investment advice
← Browse all forensic stock analyses
Data from SEC EDGAR public filings. Forensic signals flag probability, not certainty.